title: [The diagnosis and treatment of the thymic carcinoma].
abstract: Thymic carcinoma was indistinct for criteria of clinicopathological diagnosis. Recently it gets easier to diagnose thymic carcinoma, because of progression of WHO classification and immunohistochemical technique. Commonly, patients are men and in sixties. Common symptoms are chest pain and dyspnea. Most cases are advanced, over Stage III of the Masaoka's classification. Combined therapies e.g. operation, chemotherapy and radiation were done, but complete resection is difficult. Prognosis is poor, the 3- and 5-year survival is 48.7% and 40.6%.
authors.affiliation: Department of Surgery, Tokyo Metropolitan Komagome Hospital, 3-18-22 Honkamagome, Bunkyo-ku, Tokyo 113-8677, Japan.
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Moriyama
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Nishimura
authors.forename: Katuyuki
authors.initials: K
authors.lastname: Kuwabara
authors.forename: Tunekazu
authors.initials: T
authors.lastname: Hishima
authors.forename: Sachiko
authors.initials: S
authors.lastname: Moriyama
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D015996:Survival Rate; D013934:Thymectomy; D013945:Thymoma / Q000175:diagnosis / Q000401:mortality / Q000628:therapy; D013953:Thymus Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*